Genetic diversity of Pseudomonas aeruginosa isolated from the respiratory tract of patients with cystic fibrosis

Keywords

Cystic fibrosis.
Pseudomonas aeruginosa.
Antimicrobial susceptibility testing.
Microbial resistance to drugs.
Gel electrophoresis pulsed field.
Genetic variation.

How to Cite

1.
Rodrigues Nora ST, de Oliveira Garcia (orientadora) D. Genetic diversity of Pseudomonas aeruginosa isolated from the respiratory tract of patients with cystic fibrosis. Bepa [Internet]. 2016 Mar. 31 [cited 2024 Nov. 24];13(147):39-40. Available from: https://periodicos.saude.sp.gov.br/BEPA182/article/view/38107

Abstract

 Cystic fibrosis (CF) is a serious genetic disease, an autosomal recessive disorder, characterized by      an alteration in the secretion of the exocrine gland of all organism, resulting mainly in obstructive      cronic progressive lung disease. CF patients are frequently attacked by lung infections caused by      specific microorganisms. Pseudomonas aeruginosa is the most prevalent microorganism, and colonizes      approximately 70% of adolecents and adults CF patients. The damage to the lung increases when      P. aeruginosa acquires mucoid phenotype. Antimicrobial resistance has also been increased and the      emergence of resistance to carbapenems has been related. Some CF centers reported the dissemination      of P. aeruginosa among CF patients and other centers demonstrated the large variability among the      isolates not detecting transmission among the CF patients, which can indicates an environmental      acquisition instead of a common source. The aims of this study were to evaluate the susceptibility      to antimicrobial agents of P. aeruginosa isolates recovered from respiractory tract of CF outpatients      attending the outpatient clinic of Instituto da Criança (University of São Paulo Medical School) and      to analyse the genetic variability among P. aruginosa isolates recovered from diverse CF patients. A      total of 580 P. aruginosa isolates were recovered from 98 CF patients during three different periods of      collection, 129 of these isolates obtained from 11 CF patients were selected and analysed. P. aeruginosa      isolates were submitted to the disk-diffusion method testing 14 antimicrobial agents. P. aeruginosa      isolates wich presented resistance to imipenem were submitted to the phenotypical test to detect the      production of metalo-beta-lactamases, PCR for carbapenemase were carried-out by using specific      primers to detect the blaSPM, blaIMP, blaVIM, blaNDM, blaKPC, blaGES genes. The Isolate 420-2      with phenotypic profile suspected of ESBL-producing was submitted to PCR using specific primers      to detect blaCTX-M, blaGES and blaTEM genes. P. aeruginosa isolates wich presented resistance to      amikacin were submitted to the phenotypical test to detect the production of 16S rRNA methylases,      and the isolates confirmed as positive were submitted to PCR, using specific primers to detect the rmtD      and rmtG genes. The susceptibility and PFGE restriction profiles showed large variability. Thirty-five      different PFGE profiles obtained from P. aeruginosa recovered from 11 CF patients were found, only      one CF patient carried P. aeruginosa isolates with the same PFGE restriction profile along the time,      and the others CF patients carried P. aeruginosa isolates with at least two different PFGE profiles.      Some P. aeruginosa isolates presented 100% of susceptibility to antimicrobial agents, some presented      resistance to only antimicrobial agent while other showed multiresistance, however, none of them      showed 100% of resistance to all antimicrobial agents. Some P. aeruginosa isolates were phenotypically      confirmed as suspicious of MBL productors and other as 16S rRNA methylases productors. PCRs using      specific primers for blaSPM, blaIMP, blaVIM, blaNDM, blaKPC, blaGES and rmtD were negative.      Seven isolates exhibiting high-level resistance to aminoglycosides was confirmed by PCR and DNA      sequencing as producers rmtG, a new 16S rRNA methylase, recently described. PCRs for detection of      ESBL were negative. PFGE restriction and susceptibility profiles do not presented an association, once      that different PFGE restriction profiles presented identical susceptibility profiles and identical PFGE      profiles presented different susceptibility profiles. Our results demonstrated the genetic diversity of      P. aeruginosa and two patients had the same PFGE profile restriction. Diverse CF patients remained      colonized by the same clone along the time.      

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2016 Sandra Terezinha Rodrigues Nora, Doroti de Oliveira Garcia (orientadora)

Downloads

Download data is not yet available.